Critical Reviews in Oncology/Hematology
Publisher: Elsevier · ISSN 1040-8428 · 67 articles
- Circular RNAs in breast cancer immunometabolism: Mechanisms of immune regulation and metabolic reprogramming
- Baseline ECOG performance status 0 versus 1 as a modifier of treatment benefit from adding an immune checkpoint inhibitor to chemotherapy: A systematic review and meta-analysis
- Immunopharmacological advances in HBV associated hepatocellular carcinoma and EBV-related nasopharyngeal carcinoma in China: Mechanisms, therapies, and clinical perspectives
- Molecular and cellular TCR-mimic therapeutic platforms for cancer therapy: A comparative review toward a context-driven selection framework
- Bispecific immune cell engagers for solid tumors: Molecular engineering and therapeutic perspectives
- Spatial metabolic heterogeneity and immunometabolic plasticity in bone metastasis and therapeutic resistance
- From bench to bedside faster: How CAR-NK is transforming cancer research
- Cytokine and chemokine circuits in non-small cell lung cancer: Spatial biomarkers and an evidence-guided framework for combination immunotherapy
- Cancer-associated fibroblasts and tertiary lymphoid structures: Critical regulators in the tumor immune microenvironment
- Metabolic diets and fasting in oncology: Integrating guideline-based nutrition, nutrition assessments and biomarker-driven clinical pathology
- Beyond RECIST: Rethinking endpoints and biomarkers for educative cancer therapy
- From dysbiosis to precision supportive care: the gut microbiota–immune axis in pediatric acute lymphoblastic leukemia
- When is 4 Gy enough? Defining dose sufficiency and durable control in indolent B-cell lymphoma
- Current management and investigational therapeutic strategies in penile squamous cell carcinoma: A narrative review
- FGFR-altered urothelial carcinoma in the EV–pembrolizumab era: Rationale and emerging data for upfront triplet strategies
- Stromal-myeloid-lymphoid crosstalk in immune evasion and immunotherapy resistance in solid tumors
- The evolution of immunotherapy resistance in mismatch repair-deficient colorectal cancer: A spatiotemporal perspective
- Antibody–drug conjugates after EGFR-TKI resistance in EGFR-mutant NSCLC: Evidence boundaries, post-progression reassessment, and therapeutic sequencing
- Emerging role of AI in single-cell sequencing toward biomarker discovery, therapeutic target identification and precision medicine in lung cancer
- Neurofibromin in breast cancer
- Lung cancer organoid models for studying resistance to anti-angiogenic therapy: Mechanisms and applications
- Bone health in oncology: Defining biosimilar denosumab use through multidisciplinary collaboration
- Tumor-educated lymph nodes: Comprehensive remodeling or stepwise
- Breast cancer cellular and gene-based therapies: Current approaches, clinical results, and future perspectives
- Raman spectroscopy for glioma diagnosis toward precision neuro-oncology: A systematic review
- Extracellular vesicles in soft tissue sarcomas: From tumor biology to clinical translation
- Cisplatin resistance in testicular germ cell tumors: Lineage-state evolution and therapeutic re-stratification
- The tumor microenvironment of ovarian cancer through a spatial topological lens: From immune exclusion mechanisms to next-generation precision interventions
- Tumor-associated macrophages in prostate, bladder, and renal cancer metastasis: Mechanisms and therapeutic implications
- Primary pulmonary NUT carcinoma: Genomic landscape, diagnostic challenges, molecular pathogenesis, and the evolving role of radiotherapy, targeted therapies, and immunotherapy